50-167-5612

TSC22D1 Mouse anti-Human, Clone: OTI4H8, liquid, TrueMAB™

Manufacturer: OriGene

Select a Size

Pack Size SKU Availability Price
Each of 1 50-167-5612-Each-of-1 In Stock ₹ 44,954.79

50-167-5612 - Each of 1

₹ 44,954.79

In Stock

Quantity

1

Base Price: ₹ 44,954.79

GST (18%): ₹ 8,091.862

Total Price: ₹ 53,046.652

Antigen

TSC22D1

Classification

Monoclonal

Concentration

1 mg/mL

Formulation

PBS with 1% BSA, 50% glycerol and 0.02% sodium azide

Gene Accession No.

Q15714

Gene Symbols

TSC22D1

Immunogen

Full length human recombit protein of human TSC22D1 produced in HEK293T cell.

Quantity

100 μL

Primary or Secondary

Primary

Target Species

Human

Product Type

Antibody

Isotype

IgG2a

Applications

Flow Cytometry, Immunohistochemistry (Paraffin), Western Blot

Clone

OTI4H8

Conjugate

Unconjugated

Gene

TSC22D1

Gene Alias

Ptg-2, TGFB1I4, TSC22

Host Species

Mouse

Purification Method

Affinity Chromatography

Regulatory Status

RUO

Gene ID (Entrez)

8848

Content And Storage

-20° C, Avoid Freeze/Thaw Cycles

Form

Liquid

Related Products

Img

OriGene

50-167-5599

--

Img

OriGene

50-167-4760

--

Img

OriGene

50-167-5556

--

Img

OriGene

50-167-5352

--

Img

OriGene

50-167-4645

--

Img

OriGene

50-167-5856

--

Img

OriGene

50-167-4500

--

Img

OriGene

50-167-8057

--

Description

  • TSC22 domain family protein, or TSC22, is a transcription factor that belongs to the large family of early response genes
  • This transcriptional repressor is known to act on the C-type natriuretic peptide (CNP) promoter
  • TSC22 belongs to the TSC-22/Dip/Bun family and is an intracellular protein that may be found in the cytoplasm or nucleus
  • This transcription factor is known to regulate cell growth, differentiation and cell death and is involved in modulating the transcriptional activity of Smad3 and Smad4
  • This protein is ubiquitously expressed in most tissues and widely in both fetal and adult tissues
  • It is generally expressed in aortic endothelial cells, and induced by cytokines, including TGFB
  • These proteins may be possible therapeutic targets of leukemia and prostate cancer.